Table 4 Patients’ clinical characteristics at sixth month
NV group | PS/PES group | P | |
|---|---|---|---|
BMI (kg/m2) | 24.0 ± 5.0 | 24.8 ± 4.2 | 0.57 |
White blood cell count (×103/μL) | 6.1 ± 2.0 | 6.7 ± 2.3 | 0.37 |
Hemoglobin (g/dL) | 10.6 ± 2.5 | 10.8 ± 0.9 | 0.75 |
Platelet (×104/μL) | 18.6 ± 5.0 | 18.2 ± 4.7 | 0.84 |
ESA user (%) | 16 (80%) | 15 (75%) | 0.71 |
Ferritin (ng/mL) | 104.6 ± 88.1 | 88.3 ± 55.6 | 0.50 |
Phosphate (mg/dL) | 5.8 ± 1.1 | 5.2 ± 0.9 | 0.10 |
Calcium (mg/dL) | 8.9 ± 0.7 | 8.9 ± 0.6 | 1.00 |
Intact PTH (ng/mL) | 154 ± 121 | 161 ± 152 | 0.87 |
Albumin (g/dL) | 3.5 ± 0.3 | 3.5 ± 0.2 | 0.96 |
Total-cholesterol (mg/dL) | 169 ± 31 | 157 ± 29 | 0.20 |
Triglyceride (mg/dL) | 119 ± 60 | 155 ± 115 | 0.22 |
HDL-cholesterol (mg/dL) | 45 ± 12 | 45 ± 13 | 0.92 |
Ankle brachial index (right) | 1.00 ± 0.28 | 1.11 ± 0.25 | 0.33 |
Ankle brachial index (left) | 1.00 ± 0.28 | 1.08 ± 0.23 | 0.33 |
Homocysteine (nmol/mL) | 34.5 ± 17.6 | 29.6 ± 12.0 | 0.31 |
Pentosidine (μg/mL) | 0.399 ± 0.177 | 0.351 ± 0.184 | 0.40 |
hsCRP (mg/dL) | 0.179 ± 0.191 | 0.212 ± 0.201 | 0.60 |
Pentraxin 3 (ng/mL) | 4.47 ± 2.12 | 3.71 ± 2.51 | 0.31 |
Adrenaline (ng/mL) | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.81 |
Noradrenaline (ng/mL) | 0.44 ± 0.24 | 0.41 ± 0.19 | 0.73 |
Dopamine (ng/mL) | 0.04 ± 0.02 | 0.06 ± 0.04 | 0.15 |